Sage Therapeutics Inc. sued Biogen Inc. on Friday, a week after the biotech giant made an unsolicited offer to acquire the ...

Intellia Therapeutics announced its strategic priorities and key anticipated milestones for 2025. However, investors were ...

Sage Therapeutics (NASDAQ:SAGE) is reportedly suing Biogen (NASDAQ:BIIB) over enforcement of a standstill agreement in the ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...

Sage Therapeutics has sued Biogen in Delaware court, one week after receiving a $469 million buyout offer from the larger ...